ID   LIPC_RAT                Reviewed;         494 AA.
AC   P07867;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1990, sequence version 2.
DT   02-DEC-2020, entry version 153.
DE   RecName: Full=Hepatic triacylglycerol lipase;
DE            Short=HL;
DE            Short=Hepatic lipase;
DE            EC=3.1.1.3 {ECO:0000269|PubMed:1531641, ECO:0000269|PubMed:1770315, ECO:0000269|PubMed:1865764, ECO:0000269|PubMed:7074125};
DE   AltName: Full=Lipase member C;
DE   AltName: Full=Lysophospholipase;
DE            EC=3.1.1.5 {ECO:0000269|PubMed:1531641};
DE   AltName: Full=Phospholipase A1;
DE            EC=3.1.1.32 {ECO:0000269|PubMed:1531641, ECO:0000269|PubMed:1865764, ECO:0000269|PubMed:6747460, ECO:0000269|PubMed:7074125};
DE   Flags: Precursor;
GN   Name=Lipc;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=2322583; DOI=10.1016/0167-4781(90)90071-9;
RA   Sensel M.G., Legrand-Lorans A., Wang M.E., Bensadoun A.;
RT   "Isolation and characterization of clones for the rat hepatic lipase gene
RT   upstream regulatory region.";
RL   Biochim. Biophys. Acta 1048:297-302(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=3470738; DOI=10.1073/pnas.84.6.1526;
RA   Komaromy M.C., Schotz M.C.;
RT   "Cloning of rat hepatic lipase cDNA: evidence for a lipase gene family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:1526-1530(1987).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=7074125; DOI=10.1016/0005-2760(82)90130-8;
RA   Jensen G.L., Daggy B., Bensadoun A.;
RT   "Triacylglycerol lipase, monoacylglycerol lipase and phospholipase
RT   activities of highly purified rat hepatic lipase.";
RL   Biochim. Biophys. Acta 710:464-470(1982).
RN   [4]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=6747460;
RA   Landin B., Nilsson A., Twu J.S., Schotz M.C.;
RT   "A role for hepatic lipase in chylomicron and high density lipoprotein
RT   phospholipid metabolism.";
RL   J. Lipid Res. 25:559-563(1984).
RN   [5]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=1770315;
RA   Warren R.J., Ebert D.L., Mitchell A., Barter P.J.;
RT   "Rabbit hepatic lipase cDNA sequence: low activity is associated with low
RT   messenger RNA levels.";
RL   J. Lipid Res. 32:1333-1339(1991).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=1865764; DOI=10.1007/bf02537138;
RA   Wilcox R.W., Thuren T., Sisson P., Kucera G.L., Waite M.;
RT   "Hydrolysis of neutral lipid substrates by rat hepatic lipase.";
RL   Lipids 26:283-288(1991).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, AND ACTIVITY REGULATION.
RX   PubMed=1531641; DOI=10.1016/0014-5793(92)80294-q;
RA   Bohn E., Gerke V., Kresse H., Loeffler B.M., Kunze H.;
RT   "Annexin II inhibits calcium-dependent phospholipase A1 and
RT   lysophospholipase but not triacyl glycerol lipase activities of rat liver
RT   hepatic lipase.";
RL   FEBS Lett. 296:237-240(1992).
CC   -!- FUNCTION: Catalyzes the hydrolysis of triglycerides and phospholipids
CC       present in circulating plasma lipoproteins, including chylomicrons,
CC       intermediate density lipoproteins (IDL), low density lipoproteins (LDL)
CC       of large size and high density lipoproteins (HDL), releasing free fatty
CC       acids (FFA) and smaller lipoprotein particles (PubMed:7074125,
CC       PubMed:6747460, PubMed:1770315, PubMed:1865764, PubMed:1531641). Also
CC       exhibits lysophospholipase activity (PubMed:1531641). Can hydrolyze
CC       both neutral lipid and phospholipid substrates but shows a greater
CC       binding affinity for neutral lipid substrates than phospholipid
CC       substrates (PubMed:1865764). In native LDL, preferentially hydrolyzes
CC       the phosphatidylcholine species containing polyunsaturated fatty acids
CC       at sn-2 position (By similarity). {ECO:0000250|UniProtKB:P11150,
CC       ECO:0000269|PubMed:1531641, ECO:0000269|PubMed:1770315,
CC       ECO:0000269|PubMed:1865764, ECO:0000269|PubMed:6747460,
CC       ECO:0000269|PubMed:7074125}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a triacylglycerol + H2O = a diacylglycerol + a fatty acid +
CC         H(+); Xref=Rhea:RHEA:12044, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17855, ChEBI:CHEBI:18035, ChEBI:CHEBI:28868; EC=3.1.1.3;
CC         Evidence={ECO:0000269|PubMed:1531641, ECO:0000269|PubMed:1770315,
CC         ECO:0000269|PubMed:1865764, ECO:0000269|PubMed:7074125};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphocholine + H2O = a fatty acid +
CC         H(+) + sn-glycerol 3-phosphocholine; Xref=Rhea:RHEA:15177,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:16870,
CC         ChEBI:CHEBI:28868, ChEBI:CHEBI:58168; EC=3.1.1.5;
CC         Evidence={ECO:0000269|PubMed:1531641};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine + H2O = a 2-acyl-sn-
CC         glycero-3-phosphocholine + a fatty acid + H(+); Xref=Rhea:RHEA:18689,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:28868,
CC         ChEBI:CHEBI:57643, ChEBI:CHEBI:57875; EC=3.1.1.32;
CC         Evidence={ECO:0000269|PubMed:1531641, ECO:0000269|PubMed:1865764,
CC         ECO:0000269|PubMed:6747460, ECO:0000269|PubMed:7074125};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z-octadecenoyl)-sn-glycerol + H2O = (9Z)-
CC         octadecenoate + 2-(9Z-octadecenoyl)-glycerol + H(+);
CC         Xref=Rhea:RHEA:38511, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:52333, ChEBI:CHEBI:73990;
CC         Evidence={ECO:0000269|PubMed:1865764};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38512;
CC         Evidence={ECO:0000305|PubMed:1865764};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-tri-(9Z-octadecenoyl)-glycerol + H2O = (9Z)-
CC         octadecenoate + 2,3-di-(9Z)-octadecenoyl-sn-glycerol + H(+);
CC         Xref=Rhea:RHEA:38391, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:53753, ChEBI:CHEBI:75824;
CC         Evidence={ECO:0000269|PubMed:1531641, ECO:0000269|PubMed:7074125};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38392;
CC         Evidence={ECO:0000305|PubMed:1531641};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phospho-L-serine + H2O =
CC         (9Z)-octadecenoate + H(+) + sn-glycero-3-phospho-L-serine;
CC         Xref=Rhea:RHEA:40499, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:64765, ChEBI:CHEBI:74617;
CC         Evidence={ECO:0000269|PubMed:1531641};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40500;
CC         Evidence={ECO:0000305|PubMed:1531641};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-sn-glycero-3-phosphocholine + H2O = H(+) +
CC         hexadecanoate + sn-glycerol 3-phosphocholine; Xref=Rhea:RHEA:40435,
CC         ChEBI:CHEBI:7896, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16870, ChEBI:CHEBI:72998;
CC         Evidence={ECO:0000269|PubMed:1531641};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40436;
CC         Evidence={ECO:0000305|PubMed:1531641};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,3-di-(9Z-octadecenoyl)-glycerol + H2O = (9Z)-octadecenoate +
CC         3-(9Z-octadecenoyl)-sn-glycerol + H(+); Xref=Rhea:RHEA:38651,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30823,
CC         ChEBI:CHEBI:75735, ChEBI:CHEBI:75938;
CC         Evidence={ECO:0000269|PubMed:1531641};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38652;
CC         Evidence={ECO:0000305|PubMed:1531641};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-tri-(9Z-octadecenoyl)-glycerol + H2O = (9Z)-
CC         octadecenoate + di-(9Z)-octadecenoylglycerol + H(+);
CC         Xref=Rhea:RHEA:38575, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:53753, ChEBI:CHEBI:75945;
CC         Evidence={ECO:0000250|UniProtKB:P11150};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38576;
CC         Evidence={ECO:0000250|UniProtKB:P11150};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine + H2O =
CC         (9Z)-octadecenoate + (9Z-octadecenoyl)-sn-glycero-3-phosphocholine +
CC         H(+); Xref=Rhea:RHEA:38699, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:74669, ChEBI:CHEBI:76083;
CC         Evidence={ECO:0000250|UniProtKB:P11150};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38700;
CC         Evidence={ECO:0000250|UniProtKB:P11150};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-tributanoylglycerol + H2O = butanoate +
CC         dibutanoylglycerol + H(+); Xref=Rhea:RHEA:40475, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17968, ChEBI:CHEBI:35020,
CC         ChEBI:CHEBI:76478; Evidence={ECO:0000250|UniProtKB:P11150};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40476;
CC         Evidence={ECO:0000250|UniProtKB:P11150};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dihexadecanoyl-sn-glycero-3-phosphocholine + H2O = H(+) +
CC         hexadecanoate + hexadecanoyl-sn-glycero-3-phosphocholine;
CC         Xref=Rhea:RHEA:41384, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:64563, ChEBI:CHEBI:72999;
CC         Evidence={ECO:0000269|PubMed:7074125};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41385;
CC         Evidence={ECO:0000269|PubMed:7074125};
CC   -!- ACTIVITY REGULATION: Phospholipase A1 and lysophospholipase activities
CC       are inhibited by annexin II. {ECO:0000269|PubMed:1531641}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.82 mM for 1,2,3-tri-(9Z-octadecenoyl)-glycerol
CC         {ECO:0000269|PubMed:7074125};
CC         KM=0.16 mM for 1,2-di-O-palmitoyl-sn-glycero-3-phosphocholine
CC         {ECO:0000269|PubMed:7074125};
CC         Vmax=144 umol/min/mg enzyme with 1-oleoyl-sn-glycerol as substrate
CC         {ECO:0000269|PubMed:1865764};
CC         Vmax=163 umol/min/mg enzyme with 1,2-dioleoyl-sn-glycerol as
CC         substrate {ECO:0000269|PubMed:1865764};
CC         Vmax=145 umol/min/mg enzyme with 1,3-dioleoyl-sn-glycerol as
CC         substrate {ECO:0000269|PubMed:1865764};
CC         Vmax=67 umol/min/mg enzyme with phosphatidic acid as substrate
CC         {ECO:0000269|PubMed:1865764};
CC         Vmax=50 umol/min/mg enzyme with phosphatidylethanolamine as substrate
CC         {ECO:0000269|PubMed:1865764};
CC         Vmax=4 umol/min/mg enzyme with phosphatidylcholine as substrate
CC         {ECO:0000269|PubMed:1865764};
CC       pH dependence:
CC         Optimum pH is 8-9. {ECO:0000269|PubMed:7074125};
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:P11150}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:P11150}.
CC   -!- SIMILARITY: Belongs to the AB hydrolase superfamily. Lipase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X17366; CAA35241.1; -; mRNA.
DR   EMBL; X17367; CAA35242.1; -; Genomic_DNA.
DR   EMBL; M16235; AAA41335.1; -; mRNA.
DR   PIR; A27442; A27442.
DR   SMR; P07867; -.
DR   IntAct; P07867; 1.
DR   STRING; 10116.ENSRNOP00000047403; -.
DR   SwissLipids; SLP:000000571; -.
DR   ESTHER; ratno-1hlip; Hepatic_Lipase.
DR   GlyGen; P07867; 2 sites.
DR   PaxDb; P07867; -.
DR   PeptideAtlas; P07867; -.
DR   UCSC; RGD:3009; rat.
DR   RGD; 3009; Lipc.
DR   eggNOG; ENOG502QVTG; Eukaryota.
DR   InParanoid; P07867; -.
DR   PhylomeDB; P07867; -.
DR   Reactome; R-RNO-8963889; Assembly of active LPL and LIPC lipase complexes.
DR   Reactome; R-RNO-8964026; Chylomicron clearance.
DR   PRO; PR:P07867; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0005769; C:early endosome; IDA:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0034364; C:high-density lipoprotein particle; IEA:UniProtKB-KW.
DR   GO; GO:0005770; C:late endosome; IDA:RGD.
DR   GO; GO:0005902; C:microvillus; IDA:RGD.
DR   GO; GO:0052740; F:1-acyl-2-lysophosphatidylserine acylhydrolase activity; IEA:UniProtKB-EC.
DR   GO; GO:0047372; F:acylglycerol lipase activity; IDA:RGD.
DR   GO; GO:0034185; F:apolipoprotein binding; IDA:RGD.
DR   GO; GO:0052689; F:carboxylic ester hydrolase activity; IDA:RGD.
DR   GO; GO:0035478; F:chylomicron binding; IDA:BHF-UCL.
DR   GO; GO:0043395; F:heparan sulfate proteoglycan binding; IMP:RGD.
DR   GO; GO:0008201; F:heparin binding; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0016298; F:lipase activity; ISO:RGD.
DR   GO; GO:0008289; F:lipid binding; IDA:RGD.
DR   GO; GO:0004465; F:lipoprotein lipase activity; IBA:GO_Central.
DR   GO; GO:0030169; F:low-density lipoprotein particle binding; IDA:BHF-UCL.
DR   GO; GO:0004622; F:lysophospholipase activity; IDA:RGD.
DR   GO; GO:0102545; F:phosphatidyl phospholipase B activity; IEA:UniProtKB-EC.
DR   GO; GO:0052739; F:phosphatidylserine 1-acylhydrolase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008970; F:phospholipase A1 activity; IDA:UniProtKB.
DR   GO; GO:0004620; F:phospholipase activity; IBA:GO_Central.
DR   GO; GO:0016746; F:transferase activity, transferring acyl groups; IDA:RGD.
DR   GO; GO:0004806; F:triglyceride lipase activity; IDA:UniProtKB.
DR   GO; GO:0032870; P:cellular response to hormone stimulus; IEP:RGD.
DR   GO; GO:0042632; P:cholesterol homeostasis; ISO:RGD.
DR   GO; GO:0008203; P:cholesterol metabolic process; ISO:RGD.
DR   GO; GO:0030301; P:cholesterol transport; ISO:RGD.
DR   GO; GO:0034382; P:chylomicron remnant clearance; IDA:RGD.
DR   GO; GO:0034371; P:chylomicron remodeling; IDA:RGD.
DR   GO; GO:0007623; P:circadian rhythm; IEP:RGD.
DR   GO; GO:0048589; P:developmental growth; IEP:RGD.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; ISO:RGD.
DR   GO; GO:0006631; P:fatty acid metabolic process; IDA:RGD.
DR   GO; GO:0046475; P:glycerophospholipid catabolic process; IDA:RGD.
DR   GO; GO:0015012; P:heparan sulfate proteoglycan biosynthetic process; IDA:RGD.
DR   GO; GO:0034375; P:high-density lipoprotein particle remodeling; IDA:RGD.
DR   GO; GO:0016042; P:lipid catabolic process; IBA:GO_Central.
DR   GO; GO:0001889; P:liver development; IEP:RGD.
DR   GO; GO:0034383; P:low-density lipoprotein particle clearance; IDA:RGD.
DR   GO; GO:0034374; P:low-density lipoprotein particle remodeling; IDA:BHF-UCL.
DR   GO; GO:0046461; P:neutral lipid catabolic process; IDA:RGD.
DR   GO; GO:0046473; P:phosphatidic acid metabolic process; IDA:RGD.
DR   GO; GO:0046470; P:phosphatidylcholine metabolic process; IDA:RGD.
DR   GO; GO:0046337; P:phosphatidylethanolamine metabolic process; IDA:RGD.
DR   GO; GO:0006658; P:phosphatidylserine metabolic process; IDA:RGD.
DR   GO; GO:0097006; P:regulation of plasma lipoprotein particle levels; IMP:RGD.
DR   GO; GO:0010034; P:response to acetate; IEP:RGD.
DR   GO; GO:0043200; P:response to amino acid; IEP:RGD.
DR   GO; GO:0051592; P:response to calcium ion; IEP:RGD.
DR   GO; GO:0009743; P:response to carbohydrate; IEP:RGD.
DR   GO; GO:0046688; P:response to copper ion; IEP:RGD.
DR   GO; GO:0042493; P:response to drug; IEP:RGD.
DR   GO; GO:0070542; P:response to fatty acid; IEP:RGD.
DR   GO; GO:0051384; P:response to glucocorticoid; IEP:RGD.
DR   GO; GO:0009725; P:response to hormone; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0010035; P:response to inorganic substance; IEP:RGD.
DR   GO; GO:0033993; P:response to lipid; IEP:RGD.
DR   GO; GO:0032026; P:response to magnesium ion; IEP:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0043434; P:response to peptide hormone; IEP:RGD.
DR   GO; GO:0019433; P:triglyceride catabolic process; ISO:RGD.
DR   GO; GO:0070328; P:triglyceride homeostasis; ISO:RGD.
DR   GO; GO:0006641; P:triglyceride metabolic process; IDA:RGD.
DR   GO; GO:0034372; P:very-low-density lipoprotein particle remodeling; IDA:RGD.
DR   CDD; cd00707; Pancreat_lipase_like; 1.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR013818; Lipase/vitellogenin.
DR   InterPro; IPR002333; Lipase_hep.
DR   InterPro; IPR016272; Lipase_LIPH.
DR   InterPro; IPR033906; Lipase_N.
DR   InterPro; IPR001024; PLAT/LH2_dom.
DR   InterPro; IPR036392; PLAT/LH2_dom_sf.
DR   InterPro; IPR000734; TAG_lipase.
DR   PANTHER; PTHR11610; PTHR11610; 1.
DR   PANTHER; PTHR11610:SF2; PTHR11610:SF2; 1.
DR   Pfam; PF00151; Lipase; 1.
DR   Pfam; PF01477; PLAT; 1.
DR   PIRSF; PIRSF000865; Lipoprotein_lipase_LIPH; 1.
DR   PRINTS; PR00824; HEPLIPASE.
DR   PRINTS; PR00821; TAGLIPASE.
DR   SMART; SM00308; LH2; 1.
DR   SUPFAM; SSF49723; SSF49723; 1.
DR   SUPFAM; SSF53474; SSF53474; 1.
DR   PROSITE; PS00120; LIPASE_SER; 1.
DR   PROSITE; PS50095; PLAT; 1.
PE   1: Evidence at protein level;
KW   Glycoprotein; HDL; Heparin-binding; Hydrolase; Lipid degradation;
KW   Lipid metabolism; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000250|UniProtKB:P11150"
FT   CHAIN           22..494
FT                   /note="Hepatic triacylglycerol lipase"
FT                   /id="PRO_0000017771"
FT   DOMAIN          353..487
FT                   /note="PLAT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00152"
FT   REGION          255..278
FT                   /note="Essential for determining substrate specificity"
FT                   /evidence="ECO:0000250|UniProtKB:P11150"
FT   ACT_SITE        169
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        195
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10037"
FT   ACT_SITE        280
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10037"
FT   CARBOHYD        79
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        398
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CONFLICT        277
FT                   /note="N -> K (in Ref. 2; AAA41335)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        302
FT                   /note="Q -> H (in Ref. 2; AAA41335)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        308
FT                   /note="S -> T (in Ref. 2; AAA41335)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        335
FT                   /note="V -> A (in Ref. 2; AAA41335)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        369
FT                   /note="M -> I (in Ref. 2; AAA41335)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        408
FT                   /note="N -> D (in Ref. 2; AAA41335)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        451
FT                   /note="V -> L (in Ref. 2; AAA41335)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   494 AA;  55623 MW;  2A9461B1F80845EA CRC64;
     MGNHLQISVS LVLCIFIQSS ACGQGVGTEP FGRNLGATEE RKPLQKPEIR FLLFKDESDR
     LGCQLRPQHP ETLQECGFNS SHPLVMIIHG WSVDGLLETW IWKIVGALKS RQSQPVNVGL
     VDWISLAYQH YAIAVRNTRV VGQEVAALLL WLEESMKFSR SKVHLIGYSL GAHVSGFAGS
     SMGGKRKIGR ITGLDPAGPM FEGTSPNERL SPDDANFVDA IHTFTREHMG LSVGIKQPIA
     HYDFYPNGGS FQPGCHFLEL YKHIAEHGLN AITQTINCAH ERSVHLFIDS LQHSNLQNTG
     FQCSNMDSFS QGLCLNCKKG RCNSLGYDIR RIGHVKSKTL FLITRAQSPF KVYHYQFKIQ
     FINQMEKPME PTFTMTLLGT KEEIKKIPIT LGEGITSNKT YSLLITLNKD IGELIMLKFK
     WENSAVWANV WNTVQTIMLW DTEPHYAGLI VKTIWVKAGE TQQRMTFCPD NVDDLQLHPT
     QEKVFVKCDL KSKD
//
